Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

80.00

+1.14 (1.45%)

At close: Mar 19, 2026, 4:00 PM EDT

80.41

+0.41 (0.52%)

After-hours: Mar 19, 2026, 7:39 PM EDT

Dianthus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	51.09	22.79	132.33	15.37	131.65
Short-Term Investments	353.21	252.45	41.39	60.13	45.28
Cash & Short-Term Investments	404.3	275.24	173.72	75.49	176.93
Cash Growth	46.89%	58.44%	130.12%	-57.33%	18.87%
Accounts Receivable	0.05	-	-	-	-
Other Receivables	-	0.81	0.48	5.64	-
Total Trade Receivables	0.05	0.81	0.48	5.64	-
Other Current Assets	5.09	4.86	3.26	0.91	3.77
Total Current Assets	409.44	280.9	177.45	82.03	180.69
Net Property, Plant & Equipment	1.63	1.75	0.8	0.96	7.46
Long-Term Investments	110.14	81.73	-	-	-
Other Long-Term Assets	9.72	9.63	1.15	0.12	1.78
Total Assets	530.92	374.01	179.41	83.11	189.93
Accounts Payable	9.73	4.58	2.61	1.17	3.04
Accrued Expenses	19.45	13.07	6.5	6.61	7.82
Current Portion of Leases	0.37	0.32	0.42	0.35	-
Unearned Revenue	1.19	0.48	0.1	0.1	-
Total Current Liabilities	30.73	18.45	9.63	8.23	10.86
Long-Term Leases	1.02	1.17	0.17	0.44	-
Other Long-Term Liabilities	5.77	1.91	0.74	0.79	6.4
Total Long-Term Liabilities	6.79	3.08	0.9	1.23	6.4
Total Liabilities	37.52	21.53	10.54	9.45	17.26
Common Stock	0.04	0.03	0.02	-	0.06
Additional Paid-in Capital	829.6	526.73	258.23	1.66	498.21
Accumulated Other Comprehensive Income	0.49	0.11	0.05	-0.16	-0.03
Retained Earnings	-336.73	-174.39	-89.42	-45.87	-325.57
Total Common Shareholders' Equity	493.4	352.48	168.87	-44.37	172.67
Minority Interest	-	-	-	118.02	-
Shareholders' Equity	493.4	352.48	168.87	73.66	172.67
Total Liabilities & Equity	530.92	374.01	179.41	83.11	189.93
Total Debt	1.39	1.49	0.59	0.79	0
Net Cash (Debt)	402.91	273.75	173.13	74.7	176.93
Net Cash Growth	47.18%	58.12%	131.76%	-57.78%	18.87%
Net Cash Per Share	10.43	8.22	33.60	85.45	202.56
Book Value	493.4	352.48	168.87	-44.37	172.67
Book Value Per Share	12.78	10.58	32.77	-50.75	197.68
Tangible Book Value	493.4	352.48	168.87	-44.37	172.67
Tangible Book Value Per Share	12.78	10.58	32.77	-50.75	197.68

Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q